ENTITY

Deciphera Pharmaceuticals (DCPH US)

1
Analysis
Health CareUnited States
Deciphera Pharmaceuticals, Inc. operates as a biotechnology company. The Company discovers and develops kinase inhibitor treatments for various type of cancer diseases including gastrointestinal, stromal tumors, advance systemic mastocytosis, gliomas, and other solid tumors. Deciphera Pharmaceuticals serves patients globally.
more
Refresh
Company Event30 Aug 2024 21:30 • Upcoming
Add To Calendar
Company Event10 May 2024 19:00 • Upcoming
Add To Calendar
Company Event08 Feb 2024 20:00 • Upcoming
Add To Calendar
Company Event06 Feb 2024 21:00 • Latest
Company Event06 Feb 2024 06:36 • Upcoming
Add To Calendar
x